Company intelligence / Profile preview

TrueRelief

Wilmington, North Carolina, United States

Ownership: Private
Development stage: Other

Overview

TrueRelief is an FDA‑cleared, non‑opioid, non‑invasive transcutaneous electrical nerve stimulation (neuromodulation) device for temporary symptomatic relief of chronic intractable pain and as an adjunct in post‑surgical and post‑traumatic acute pain, with sham‑controlled clinical data (including a JAMA Network Open cesarean section study) showing ~47% reduction in opioid use and substantial pain score reductions.[3][4][5]

Therapeutic areas: RheumatologyCardiovascularNeurologyOther
Modalities: DeviceNon-pharmacological therapyNeuromodulation device
Industry: Therapeutic Medical Devices

Partnerships

UnitedHealth Group Orthology Physical Wellness division (system‑wide utilization pilot and rollout in physical therapy clinics)[3][4][6]

Beyond the preview

Go deeper on TrueRelief.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on TrueRelief.

Explore the full profile